Ajooni Biotech Limited (AJOONI.NS)
INR 7.29
(-2.15%)
INR 7.29
(-2.15%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 800 Million | 744.87 Million | 740.37 Million | 510.38 Million | 400.32 Million | 397.18 Million |
| Cost of Revenue | 741.98 Million | 657.42 Million | 640.13 Million | 430.12 Million | 349.12 Million | 364.71 Million |
| Gross Profit | 58.02 Million | 87.44 Million | 100.24 Million | 80.26 Million | 51.2 Million | 32.46 Million |
| Operating Expenses | 44.24 Million | 69.83 Million | 77.99 Million | 68.13 Million | 42.31 Million | 28.34 Million |
| Selling, General and Administrative Expenses | 32.37 Million | 20.49 Million | 29.32 Million | 33.86 Million | 15.52 Million | 9.53 Million |
| Research and Development Expenses | 670 Thousand | 2.42 Million | 497.52 Thousand | 699.02 Thousand | 2.73 Million | - |
| Other Expenses | - | 2.94 Million | 375.74 Thousand | 169.97 Thousand | 193.07 Thousand | 681.4 Thousand |
| Cost and Expenses | 786.23 Million | 727.26 Million | 718.13 Million | 498.25 Million | 391.43 Million | 393.06 Million |
| Operating Income | 15.12 Million | 19.74 Million | 21.54 Million | 10.89 Million | 7.68 Million | 3.15 Million |
| Interest Expense | 5.56 Million | 4.78 Million | 5.38 Million | 4.94 Million | 3.14 Million | 1.09 Million |
| Income Tax Expense | 8.34 Million | 4.52 Million | 4.12 Million | 1.31 Million | 1.33 Million | 639.48 Thousand |
| Earnings before Tax | 29.96 Million | 15.76 Million | 14.61 Million | 5.04 Million | 4.8 Million | 4.74 Million |
| Net Income | 21.61 Million | 11.24 Million | 10.48 Million | 3.73 Million | 3.46 Million | 4.1 Million |
| Earnings Per Share Basic | 0.25 | 1.94 | 0.18 | 0.07 | 0.07 | 0.11 |
| Earnings Per Share Diluted | 0.25 | 1.94 | 0.18 | 0.07 | 0.07 | 0.11 |
| Weighted Average Shares Outstanding | 86.44 Million | 5.79 Million | 56.73 Million | 56.73 Million | 52.95 Million | 38.64 Million |
| Weighted Average Shares Outstanding (Diluted) | 86.44 Million | 5.79 Million | 56.73 Million | 56.73 Million | 52.95 Million | 38.64 Million |
| Gross Margin | 0.07 | 0.12 | 0.14 | 0.16 | 0.13 | 0.08 |
| EBIT Margin | 0.06 | 0.04 | 0.05 | 0.03 | 0.03 | 0.02 |
| Profit Margin | 0.03 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 |
| EBITDA | 44.27 Million | 30.6 Million | 31.11 Million | 15.76 Million | 12.47 Million | 7.55 Million |
| Earnings Before Tax Margin | 0.02 | 0.03 | 0.03 | 0.02 | 0.02 | 0.01 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 256.58 Million | 800 Million | 195.81 Million | 200.5 Million | 194.79 Million | 210.02 Million |
| Cost of Revenue | 232.66 Million | 741.98 Million | 158.61 Million | 192.59 Million | 183.22 Million | 195.81 Million |
| Gross Profit | 23.92 Million | 58.02 Million | 37.19 Million | 7.91 Million | 11.57 Million | 14.21 Million |
| Operating Expenses | 16.52 Million | 44.24 Million | 23.68 Million | 16.62 Million | 7.35 Million | 9.65 Million |
| Selling, General and Administrative Expenses | 16.52 Million | - | 23.68 Million | 16.62 Million | 7.35 Million | 9.65 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | -16.52 Million | -76 Thousand | - | - | - | - |
| Cost and Expenses | 249.19 Million | 786.23 Million | 182.29 Million | 209.21 Million | 190.57 Million | 205.46 Million |
| Operating Income | 7.39 Million | 13.77 Million | 13.51 Million | -8.7 Million | 4.22 Million | 4.55 Million |
| Interest Expense | 1.5 Million | 5.56 Million | 1.1 Million | 1.2 Million | 1.91 Million | 1.33 Million |
| Income Tax Expense | 1.57 Million | 8.34 Million | 5.83 Million | 1.42 Million | 1.16 Million | -76 Thousand |
| Earnings before Tax | 6.26 Million | 29.96 Million | 14.98 Million | 5.82 Million | 5.2 Million | 3.94 Million |
| Net Income | 4.68 Million | 21.61 Million | 9.14 Million | 4.39 Million | 4.04 Million | 4.01 Million |
| Earnings Per Share Basic | 0.03 | - | 0.09 | 0.22 | 0.20 | 0.20 |
| Earnings Per Share Diluted | 0.03 | - | 0.09 | 0.22 | 0.20 | 0.20 |
| Weighted Average Shares Outstanding | 156.06 Million | 99.37 Million | 99.37 Million | 19.87 Million | 19.87 Million | 19.87 Million |
| Weighted Average Shares Outstanding (Diluted) | 156.06 Million | 99.37 Million | 99.37 Million | 19.87 Million | 19.87 Million | 19.87 Million |
| Gross Margin | 0.09 | 0.07 | 0.19 | 0.04 | 0.06 | 0.07 |
| EBIT Margin | 0.04 | - | 0.08 | -0.03 | 0.03 | 0.03 |
| Profit Margin | 0.02 | 0.03 | 0.05 | 0.02 | 0.02 | 0.02 |
| EBITDA | 9.62 Million | - | 15.9 Million | -6.57 Million | 6.36 Million | 6.65 Million |
| Earnings Before Tax Margin | 0.03 | 0.02 | 0.07 | -0.04 | 0.02 | 0.02 |
688518
KANORICHEM
8349
8622
EU
0237